SCHEMBL4789869

SCHEMBL4789869

Cc1ccccc1N(C)c1c[c]ccc1

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.33
TSHR P16473 1/20 0.31
ACHE P22303 1/20 0.31
MAPK13 O15264 1/20 0.30
MAPK12 P53778 1/20 0.30
MAPK11 Q15759 1/20 0.30
MAPK14 Q16539 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL698362 0.79 LMNA (0.40)
SCHEMBL20384981 0.78 TSHR (0.41) SIGMAR1TSHRACHE
SCHEMBL2198610 0.78 TSHR (0.41) SIGMAR1TSHRACHE
Hydrochloric Acid SCHEMBL28328614 0.75 TSHR (0.38) SIGMAR1TSHRACHE
SCHEMBL2620728 0.73 ACHE (0.50) SIGMAR1TSHRACHE
SCHEMBL60023 0.72
SCHEMBL13367414 0.71 TSHR (0.46) SIGMAR1TSHRACHEMAPK13MAPK12
SCHEMBL13367468 0.70 CSF1R (0.45) SIGMAR1TSHRACHEMAPK13MAPK12
Hydroquinone SCHEMBL28096005 0.70 HSD17B1 (0.42) SIGMAR1TSHR
SCHEMBL3894433 0.70 ALDH1A1 (0.39) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1618098-A4 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS AND THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE PCT THERAPEUTICS INC (US) 2008-07-16 EP disclosed
EP-1618098-A2 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS AND THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE PCT Therapeutics Inc. (US) 2006-01-25 EP disclosed
WO-2004091502-A2 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS PTC THERAPEUTICS, INC. (US) 2004-10-28 WO disclosed